BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29176314)

  • 21. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.
    Alam H; Bhate AV; Gangadaran P; Sawant SS; Salot S; Sehgal L; Dange PP; Chaukar DA; D'cruz AK; Kannanl S; Gude R; Kane S; Dalal SN; Vaidya MM
    BMC Cancer; 2012 Jan; 12():32. PubMed ID: 22264292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
    Xiong W; Li D; Ao F; Tu Z; Xiong J
    Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis.
    Liu P; Wang Y; Li X; Liu Z; Sun Y; Liu H; Shao Z; Jiang E; Zhou X; Shang Z
    Cancer Sci; 2024 May; 115(5):1433-1445. PubMed ID: 38494608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.
    Pitt SC; Chen H; Kunnimalaiyaan M
    Ann Surg Oncol; 2009 Oct; 16(10):2936-42. PubMed ID: 19588205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.
    Alam H; Gangadaran P; Bhate AV; Chaukar DA; Sawant SS; Tiwari R; Bobade J; Kannan S; D'cruz AK; Kane S; Vaidya MM
    PLoS One; 2011; 6(11):e27767. PubMed ID: 22114688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner.
    Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L
    Neoplasia; 2012 Aug; 14(8):719-31. PubMed ID: 22952425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.
    Vangamudi B; Peng DF; Cai Q; El-Rifai W; Zheng W; Belkhiri A
    Mol Cancer; 2010 Sep; 9():240. PubMed ID: 20836878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ueda M; Ota K; Ota T; Sueyoshi T; Oike Y; Ibusuki M; Hiraki A; Nakayama H; Shinohara M; Ando Y
    J Pathol; 2011 Sep; 225(1):142-50. PubMed ID: 21710490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
    Knowles JA; Golden B; Yan L; Carroll WR; Helman EE; Rosenthal EL
    Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review.
    Rajendran P; Sekar R; Dhayasankar PS; Ali EM; Abdelsalam SA; Balaraman S; Chellappan BV; Metwally AM; Abdallah BM
    Int J Med Sci; 2024; 21(6):1165-1175. PubMed ID: 38774756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner.
    Wang QL; Wang L; Li QY; Li HY; Lin L; Wei D; Xu JY; Luo XJ
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4447-4459. PubMed ID: 38108838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
    Mukudai Y; Kondo S; Fujita A; Yoshihama Y; Shirota T; Shintani S
    Cell Oncol (Dordr); 2013 Jun; 36(3):233-45. PubMed ID: 23529586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.
    Gayer CP; Chaturvedi LS; Wang S; Craig DH; Flanigan T; Basson MD
    J Biol Chem; 2009 Jan; 284(4):2001-11. PubMed ID: 19047055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
    Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
    J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
    Xiang L; Xie G; Ou J; Wei X; Pan F; Liang H
    PLoS One; 2012; 7(4):e35378. PubMed ID: 22496919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRTF-A/SRF signaling suppresses invasion of oral squamous cell carcinoma.
    Yang D; Yang D; He Y; Liu J; Song Y; Zhou Y; Jiang L; Zeng X; Xu X; Xu H; Li J; Dan H
    Oral Dis; 2024 May; 30(4):1919-1934. PubMed ID: 37154247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.